The aim of this study is to evaluate the effect of these factors and stroke itself on osteoporosis developing after stroke. Thus, the expected benefit of the study is to contribute to the identification and determination of the need for treatment in high-risk patients through further studies. There are no expected risks from the study.
Study Type
OBSERVATIONAL
Enrollment
84
Patients who have had a stroke and are at risk of fracture, and for whom routine assessment requires Bone Mineral Density (BMD) testing, will be included in the study. In addition, patients who have already undergone BMD testing for osteoporosis screening and who present to the outpatient clinic, with similar age and comorbidities, will be screened from the system, and 28 non-stroke patients who agree to participate will be included in the study.
Ankara Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye)
RECRUITINGBone Mineral Density
Time frame: First day of hospitalization
Brunnstrom
Time frame: First day of hospitalization
Modified Barthel Index
Time frame: First day of hospitalization
Modified Ashworth Scale
Time frame: First day of hospitalization
Modified Fall Impact Scale
Time frame: First day of hospitalization
Vitamin D, prealbumin, and albumin
Time frame: First day of hospitalization
Baseline Digital Hand Dynamometer 198 LB/90 kg
Patients' muscle strength will be measured using a Baseline Digital Hand Dynamometer at 198 LB/90 kg for both the dominant and non-dominant extremities.
Time frame: First day of hospitalization
Measurements of quadriceps muscle thickness and biceps muscle thickness
Regional sarcopenia of the plegic and non-plegic extremities will also be assessed using the STAR formula with measurements of anterior thigh muscle thickness and anterior arm muscle thickness by ultrasound.
Time frame: First day of hospitalization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.